Hochschulschrift
Region-specific characterization of the cuprizone model for Multiple Sclerosis and impairment of remyelination by corticosteroids
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Aachen, Techn. Hochsch., Diss., 2011
- Schlagwort
-
Myelin , Entmarkung , Remyelinisierung , Corticosteroide
Hirnkrankheit
Neuropsychiatrie
Nervenkrankheit
- Ereignis
-
Veröffentlichung
- (wo)
-
Aachen
- (wer)
-
Hochschulbibliothek der Rheinisch-Westfälischen Technischen Hochschule Aachen
- (wann)
-
2011
- Urheber
- URN
-
urn:nbn:de:hbz:82-opus-37812
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 05:29 UTC
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
- Clarner, Tim Guido
- Hochschulbibliothek der Rheinisch-Westfälischen Technischen Hochschule Aachen
Entstanden
- 2011
Ähnliche Objekte (12)
Region-specific characterization of the cuprizone model for Multiple Sclerosis and impairment of remyelination by corticosteroids
Promoting remyelination in multiple sclerosis
Brain region-specific enhancement of remyelination and prevention of demyelination by the CSF1R kinase inhibitor BLZ945
In vivo analysis of demyelination and remyelination in an animal model of multiple sclerosis
Remyelination promoting therapies in multiple sclerosis animal models: a systematic review and meta-analysis
Axonal degeneration and protection during early remyelination in multiple sclerosis and an animal model
Glia during de-and remyelination
Impact of multiple sclerosis treatments on the rate of cerebral remyelination assessed by advanced neuroimaging
Surfen, a proteoglycan binding agent, reduces inflammation but inhibits remyelination in murine models of Multiple Sclerosis
Transcript profiling of different types of multiple sclerosis lesions yields FGF1 as a promoter of remyelination
TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis
Butyrate suppresses demyelination and enhances remyelination
Region-specific characterization of the cuprizone model for Multiple Sclerosis and impairment of remyelination by corticosteroids
Promoting remyelination in multiple sclerosis
Brain region-specific enhancement of remyelination and prevention of demyelination by the CSF1R kinase inhibitor BLZ945
In vivo analysis of demyelination and remyelination in an animal model of multiple sclerosis
Remyelination promoting therapies in multiple sclerosis animal models: a systematic review and meta-analysis
Axonal degeneration and protection during early remyelination in multiple sclerosis and an animal model
Glia during de-and remyelination
Impact of multiple sclerosis treatments on the rate of cerebral remyelination assessed by advanced neuroimaging
Surfen, a proteoglycan binding agent, reduces inflammation but inhibits remyelination in murine models of Multiple Sclerosis
Transcript profiling of different types of multiple sclerosis lesions yields FGF1 as a promoter of remyelination
TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis
Butyrate suppresses demyelination and enhances remyelination
Region-specific characterization of the cuprizone model for Multiple Sclerosis and impairment of remyelination by corticosteroids
Promoting remyelination in multiple sclerosis
Brain region-specific enhancement of remyelination and prevention of demyelination by the CSF1R kinase inhibitor BLZ945
In vivo analysis of demyelination and remyelination in an animal model of multiple sclerosis
Remyelination promoting therapies in multiple sclerosis animal models: a systematic review and meta-analysis
Axonal degeneration and protection during early remyelination in multiple sclerosis and an animal model
Glia during de-and remyelination
Impact of multiple sclerosis treatments on the rate of cerebral remyelination assessed by advanced neuroimaging
Surfen, a proteoglycan binding agent, reduces inflammation but inhibits remyelination in murine models of Multiple Sclerosis
Transcript profiling of different types of multiple sclerosis lesions yields FGF1 as a promoter of remyelination
TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis